Progenity, a biotech company innovating in the fields of women’s health, gastrointestinal health, and oral biotherapeutics had announced Adi Mohatny as the company’s new CEO. he also joins Progenity’s Board of Directors. Progenity applies a multi-omics approach, combining genomics, epigenomics, proteomics, and metabolomics to its molecular testing products and to the development of a suite of investigational ingestible devices designed to provide…
